explor
longitudin
chang
pattern
key
laboratori
test
patient
identifi
independ
prognost
factor
examin
associ
laboratori
find
outcom
patient
multicent
studi
prospect
includ
patient
treat
jilin
provinc
januari
may
laboratori
test
includ
haematolog
biochem
immunolog
test
laboratori
find
characterist
epidemiolog
demograph
data
extract
electron
medic
record
eosinopenia
shown
case
onset
averag
valu
eosinophil
continu
significantli
increas
thereaft
lymphopenia
found
case
onset
averag
valu
lymphocyt
slowli
elev
day
thrombocytopenia
shown
case
onset
averag
valu
mean
platelet
volum
decreas
sharpli
day
valu
aspart
aminotransferas
lactat
dehydrogenas
creatin
kinas
creatinin
kinasemusclebrain
activ
cardiac
troponin
serum
cardiac
marker
beyond
upper
limit
ri
onset
draft
manuscript
author
review
edit
manuscript
approv
final
version
manuscript
longitudin
analysi
patient
rapidli
acut
respiratori
failur
acut
respiratori
distress
syndrom
metabol
acidosi
coagulopathi
septic
shock
clinic
practic
found
patient
condit
suddenli
worsen
bring
challeng
treatment
earli
identif
risk
factor
sever
ill
facilit
appropri
treatment
prognosi
therefor
necessari
make
comprehens
judgment
laboratori
find
patient
condit
although
studi
report
epidemiolog
featur
molecular
characterist
clinic
manifest
chest
imag
laboratori
find
patient
studi
crosssect
studi
reflect
whole
cours
diseas
best
knowledg
comprehens
investig
dynam
chang
trajectori
time
multipl
laboratori
data
recov
patient
covid
yet
report
tempor
chang
pattern
laboratori
data
may
provid
insight
clue
whole
cours
diseas
therefor
essenti
identifi
longitudin
differenti
laboratori
characterist
patient
present
research
aim
investig
longitudin
chang
pattern
laboratori
data
recov
patient
reveal
associ
laboratori
find
outcom
patient
provid
prognost
factor
laboratori
find
perform
observ
studi
laboratori
characterist
confirm
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
patient
confirm
case
defin
posit
result
realtim
reversetranscriptasepolymerasechainreact
rtpcr
assay
sputum
throat
swab
pecimen
multicent
studi
patient
recruit
multicent
studi
three
design
tertiari
hospit
jilin
provinc
includ
first
hospit
jilin
univers
changchun
infecti
diseas
hospit
sipe
infecti
diseas
hospit
januari
march
laboratori
find
characterist
epidemiolog
demograph
data
retriev
electron
medic
record
two
research
independ
check
data
incub
period
defin
durat
contact
transmiss
sourc
onset
symptom
date
last
discharg
patient
march
final
date
followup
studi
approv
ethic
committe
first
hospit
jilin
univers
changchun
infecti
diseas
hospit
sipe
infecti
diseas
hospit
written
inform
consent
waiv
review
emerg
need
collect
clinic
data
laboratori
confirm
achiev
changchun
center
diseas
control
prevent
sipe
center
diseas
control
prevent
suspici
posit
sputum
throat
swab
specimen
transport
confirm
jilin
provinci
center
diseas
control
prevent
laboratori
diagnosi
specimen
test
rtpcr
rna
rtpcr
assay
conduct
accord
manufactur
protocol
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
shanghai
biogerm
medic
technolog
co
ltd
shanghai
geneodx
biotech
co
ltd
patient
recov
hospit
result
two
rtpcr
test
taken
hour
apart
neg
laboratori
assess
includ
haematolog
biochem
immunolog
test
determin
three
design
tertiari
hospit
test
kit
calibr
qualiti
control
product
match
equip
doctor
technician
nurs
studi
receiv
unifi
train
health
commiss
jilin
provinc
ministri
health
peopl
republ
china
publish
common
biochem
analyt
blood
cell
analysi
refer
interv
chines
adult
refer
interv
item
three
design
tertiari
hospit
use
china
industri
standard
order
estim
tempor
trajectori
primari
marker
local
regress
curv
loess
diagram
use
r
locfit
packag
correspond
confid
interv
estim
valu
day
given
aid
bootstrap
method
bootstrap
data
made
identifi
test
prognost
valu
predict
patient
recoveri
time
univari
cox
model
firstli
fit
upon
marker
pvalu
univari
analysi
gender
age
three
featur
select
method
lasso
method
multivari
cox
regress
backward
select
multivari
cox
regress
stepwis
select
use
refin
list
final
model
nomogram
made
illustr
select
marker
associ
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
chanc
recoveri
analysi
carri
use
r
languag
version
wwwrprojectorg
case
diagnos
three
design
tertiari
hospit
jilin
provinc
diagnos
common
type
sever
type
median
age
year
rang
year
old
iqr
year
old
case
femal
median
interv
incub
period
day
iqr
final
date
followup
patient
discharg
averag
length
hospit
stay
day
iqr
case
travel
histori
wuhan
travel
histori
outsid
wuhan
primari
case
left
jilin
provinc
recent
close
exposur
histori
import
case
secondari
case
close
exposur
histori
primari
contact
transmiss
rout
shown
figur
baselin
characterist
recov
case
shown
tabl
leukocyt
paramet
count
white
blood
cell
wbc
neutrophil
ne
lymphocyt
ly
eosinophil
eo
lower
limit
ri
account
basophil
ba
monocyt
mo
beyond
upper
limit
ri
account
onset
erythrocyt
paramet
decreas
count
red
blood
cell
rbc
hemoglobin
hgb
hematocrit
hct
mean
corpuscular
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
volum
mcv
mean
corpuscular
hemoglobin
mch
account
platelet
paramet
count
platelet
count
plt
valu
thrombocytocrit
pct
lower
limit
ri
account
respect
coagul
paramet
valu
activ
partial
thromboplastin
time
aptt
prothrombin
time
pt
intern
normal
ratio
inr
upper
limit
ri
found
case
valu
fibrinogen
fbg
lower
limit
ri
found
case
concentr
highsensit
creactiv
protein
hscrp
higher
upper
limit
ri
case
serum
cardiac
marker
valu
aspart
aminotransferas
ast
lactat
dehydrogenas
ldh
creatin
kinas
ck
creatinin
kinasemusclebrain
activ
ckmb
cardiac
troponin
ctni
beyond
upper
limit
ri
account
liver
function
test
valu
alanin
aminotransferas
alt
glutamyl
transpeptidas
ggt
total
bilirubin
tbil
direct
bilirubin
dbil
upper
limit
ri
account
valu
cholinesteras
che
total
protein
tp
albumin
alb
globulin
glb
indirect
bilirubin
ibil
lower
limit
ri
account
kidney
function
test
valu
blood
urea
nitrogen
bun
creatinin
cr
upper
limit
ri
account
respect
electrolyt
test
potassium
k
sodium
na
chlorid
cl
lower
limit
ri
account
respect
gender
differ
rbc
hgb
hct
mcv
mch
mean
corpuscular
hemoglobin
concentr
mchc
pct
thrombin
time
tt
pt
ck
ggt
tbil
dbil
cr
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
cl
laboratori
find
patient
onset
hospit
admiss
shown
tabl
averag
valu
eo
near
lower
limit
ri
onset
continu
significantli
increas
alway
upper
limit
ri
discharg
averag
valu
ne
gradual
increas
onset
peak
day
steadili
fall
lower
limit
ri
averag
valu
ly
approach
lower
limit
ri
first
day
rose
slowli
thereaft
reach
peak
around
day
ratio
neli
peak
day
slowli
declin
thereaft
averag
valu
mo
ba
show
ushap
trend
peak
day
day
respect
platelet
parametersplt
pct
mean
platelet
volum
mpv
within
ri
case
averag
valu
pct
peak
day
slowli
declin
thereaft
averag
valu
mpv
decreas
sharpli
day
even
close
lower
limit
ri
signific
chang
erythrocyt
paramet
includ
rbc
hgb
hct
mch
mchc
howev
averag
valu
mcv
show
upward
trend
day
averag
valu
ctni
sharpli
declin
averag
valu
carbondioxid
combin
power
co
signific
increas
throughout
cours
diseas
haematolog
biochem
immunolog
test
found
signific
trend
time
interestingli
averag
valu
serum
na
show
upward
trend
day
trajectori
laboratori
test
time
shown
figur
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
measur
test
earli
period
hospit
day
day
summar
respect
mean
use
hereaft
analysi
univari
cox
regress
model
indic
pct
plt
eo
eo
mo
co
met
inclus
criteria
ie
p
correl
plot
test
age
present
figur
expect
pct
plt
eo
eo
highli
posit
correl
refin
featur
select
step
carri
test
age
gender
candid
marker
lasso
select
eo
age
plt
co
backward
select
chose
co
stepwis
select
chose
eo
plt
co
auc
roc
curv
day
three
model
present
figur
well
basic
model
model
outperform
model
sinc
eo
eo
highli
correl
age
eo
plt
co
includ
final
model
marker
age
statist
signific
p
shown
nomogram
final
model
figur
plt
co
earli
day
low
chanc
quick
recoveri
decreas
wherea
eo
earli
day
low
probabl
quick
recoveri
increas
case
diagnos
three
design
tertiari
hospit
jilin
provinc
middl
elderli
age
present
studi
final
date
followup
patient
recov
discharg
case
import
primari
secondari
case
account
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
respect
present
studi
patient
sever
type
year
old
present
studi
eosinopenia
shown
case
onset
similar
recent
research
shown
trajectori
figur
level
eo
continu
increas
thereaft
discharg
therefor
longitudin
chang
pattern
eo
could
use
earli
predictor
case
typic
clinic
manifest
chang
chest
ct
without
lymphopenia
eosinopenia
predict
diagnosi
confirm
case
continu
rise
eo
valu
may
sign
recoveri
valu
ly
case
declin
onset
present
studi
consist
report
lymphopenia
show
may
mainli
act
lymphocyt
coronaviru
averag
valu
ly
slowli
elev
day
peak
around
day
well
peak
day
declin
thereaft
ratio
neli
indic
gradual
return
number
function
lymphocyt
recov
patient
recent
studi
incid
sever
ill
age
valu
plt
lower
limit
ri
case
onset
similar
recent
research
case
hospit
significantli
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
lower
report
case
hospit
china
thrombocytopenia
significantli
patient
sever
type
critic
type
present
studi
averag
valu
pct
peak
day
slowli
declin
thereaft
averag
valu
mpv
decreas
sharpli
day
longitudin
chang
pattern
indic
platelet
paramet
may
predictor
recov
patient
erythrocyt
parameterscount
rbc
hgb
hct
mcv
mch
less
lower
limit
ri
onset
howev
averag
valu
mcv
show
upward
trend
day
indic
constant
recoveri
thereaft
base
tempor
trajectori
key
laboratori
test
figur
specul
medic
intervent
patient
would
experi
improv
approxim
one
week
hospit
stay
investig
warrant
test
day
turn
point
recoveri
medic
intervent
acut
cardiac
injuri
found
approxim
patient
present
studi
valu
ast
ldh
ck
ckmb
ctni
serum
cardiac
marker
beyond
upper
limit
ri
onset
consist
report
cardiac
injuri
common
condit
among
hospit
patient
associ
higher
risk
inhospit
mortal
therefor
necessari
activ
prevent
respond
myocardi
injuri
reduc
possibl
irrevers
remodel
myocardium
hepat
injuri
also
found
present
studi
valu
alt
ggt
tbil
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
dbil
beyond
upper
limit
ri
valu
che
tp
alb
glb
ibil
lower
limit
ri
liver
function
test
indic
gentli
hepat
injuri
patient
although
kidney
injuri
sever
valu
bun
cr
upper
limit
ri
also
found
case
respect
disturb
electrolyt
balanc
also
common
condit
patient
decreas
valu
k
na
cl
studi
age
eo
plt
co
select
use
prognost
factor
affect
prognosi
recoveri
lasso
backward
stepwis
nomogram
establish
base
age
eo
plt
co
use
predict
recoveri
rate
suggest
patient
improv
risk
stratif
manag
accord
age
eo
plt
co
model
disadvantag
follow
case
enrol
present
studi
sampl
size
may
larg
nevertheless
given
jilin
provinc
least
affect
area
china
studi
cover
approxim
diagnos
case
jilin
provinc
addit
longitudin
measur
laboratori
test
collect
render
sampl
size
studi
adequ
reliabl
statist
estim
data
clinic
manifest
patient
includ
sinc
studi
mainli
focus
tempor
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
trajectori
laboratori
find
longitudin
chang
pattern
key
laboratori
test
patient
found
averag
valu
eo
continu
significantli
increas
averag
valu
mpv
decreas
sharpli
day
age
eo
plt
co
may
use
predict
recoveri
probabl
risk
stratif
manag
could
improv
patient
accord
tempor
trajectori
laboratori
test
declar
compet
interest
studi
approv
ethic
committe
first
hospit
jilin
univers
changchun
infecti
diseas
hospit
sipe
infecti
diseas
hospit
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
